Publication | Open Access
A phase I study of ifosfamide with mesna given daily for 3 consecutive days to children with malignant solid tumors
14
Citations
11
References
1993
Year
Delivery of ifosfamide daily for 3 days is feasible and safe at recommended dosages of 2133 mg/m2/d for children with prior exposure to platinum and 3000 mg/m2/d for those without prior exposure.
| Year | Citations | |
|---|---|---|
Page 1
Page 1